What's breaking now, across thousands of outlets.
The Fidelity-backed biotech now has 15-month data from a small study of its RNA-splicing therapy.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
A new program in B.C. trains advanced paramedics in how to treat heart attack patients with thrombolysis and clot-dissolving medication
Researchers at the National University of Singapore have used brief pulses of a weak magnetic field to eliminate breast tumors in 75% of the mice they tested, without any chemotherapy.
Pancreatic cancer is typically caught in its latest stages, when it is hardest to treat
Researchers combined a blood test to measure the biomarker p-tau217 and a genetic test that looks for a variant of the APOE gene.
Some 41 states restrict abortions, a ‘core component’ of maternal fetal practice, high-risk pregnancy non-profit says Maternal fetal specialists should see abortion care as a “core component” of their…
